Skip to content

Rosacea diagnostic criteria national multi-center clinical validation program

Rosacea diagnostic criteria national multi-center clinical validation program

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016861
Enrollment
Unknown
Registered
2018-06-29
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

Gold Standard:The American Rosacea Association of Experts Committee was established in 2002 and revised in 2004 (referred to as the international standard). This standard states that: As long as the c
2, persistent erythema 3, papules, pust
Index test:Diagnostic&#32
for&#32
Rosacea&#32
in&#32
the&#32
Population:&#32
Conditions:&#32
Parotid/Period/Nose&#32
Paroxysmal&#32
Flushing&#32
or&#32
Erythema&#32

Sponsors

Central South University Xiangya Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as rose acne based on the diagnostic criteria of American rose acne (combined with disease examination when diagnosis is difficult); 2. facial common skin diseases such as seborrheic dermatitis, facial eczema, acne, etc.; 3. Voluntary Signing of Informed Consent.

Exclusion criteria

Exclusion criteria: Excludes other diseases with facial redness (diseases caused by blood routine, antinuclear antibody elimination of connective tissue diseases) (including rosacea) and other facial dermatological diseases such as seborrheic dermatitis, facial eczema, acne, etc.

Design outcomes

Primary

MeasureTime frame
SEN, SPE;

Countries

China

Contacts

Public ContactXie Hongfu

Central South University Xiangya Hospital

Xiehongfu1964@aliyun.com+86 13908455353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026